ACTION

Webinar: The results are in! Now what? - webinar materials now available online

The first ever phase III trials for multidrug-resistant TB (MDR-TB) finally yielded results. Treatment Action Group (TAG), ACTION, and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) presented the results in a webinar held on 12 December 2017. The webinar explored implications for the field, from the delamanid C213 trial and the STREAM trial to evaluate the shorter regimen for MDR-TB.

Read More →

Webinar: The results are in! Now what?

Exploring the implications of the delamanid phase III and STREAM trial results

Read More →

Call for applications: TB R&D media training

The week of 30 January 2017, ACTION will host a public speaking and media skills training for TB research and development (R&D) researchers and affected communities.

Read More →

From policy to practice: How the TB-HIV response is working

A new research report from ACTION shows that while countries have taken steps in the right direction since 2014 to combat the deadly duo of TB and HIV, policy improvements have not all translated into changes at the facility level. Moreover, the burden to carry out TB-HIV activities still falls heavily on under-resourced TB programs.

Read More →

Call for applications: TB & Global Fund spokesperson training

From October 5-8 2015, the ACTION global health advocacy partnership (www.ACTION.org) will host a public speaking and media skills training for TB and Global Fund advocates working in countries with high burdens of tuberculosis (TB).

Read More →

Community Corner at 2014 Union World Conference on Lung Health

The Community Corner is a space for all Union conference attendees to gather, discuss, debate and share ideas on the most pressing issues facing the fight against tuberculosis.

Read More →

ACTION: From rhetoric to reality: An analysis of efforts to scale up the response to TB-HIV

A new research report from ACTION global health shows that joint TB-HIV activities are neglected by HIV programs and overwhelmingly carried out by TB programs, and that global guidelines to address TB-HIV have not been prioritized by leading donors and affected countries. 

Read More →

ACTION partnership applauds U.S. Government for its leadership on TB-HIV

The ACTION global health partnership applauds the U.S. Government for its leadership on creating a comprehensive plan to make the end of AIDS a reality, and recognizing the critical role of addressing tuberculosis (TB) to end the global HIV/AIDS epidemic.

Read More →

ACTION: Children and tuberculosis: From neglect to action

ACTION has released its second brief on children and TB, issuing recommendations for the international community and affected countries to combat this neglected epidemic.

Read More →

ACTION commends price reductions on improved TB test to speed diagnosis, save lives

On August 7, 2012, the United States President’s Emergency Plan for AIDS Relief (PEPFAR), the United States Agency for International Development (USAID), UNITAID, and the Bill & Melinda Gates Foundation announced an agreement that will significantly reduce the cost of the rapid TB diagnostic test Xpert MTB/RIF (commonly referred to as GeneXpert)  in 145 high-burden and developing countries. ACTION issues the following statement in response:

Read More →

Page 1 of 2 · Total posts: 10

1 2 Last→